Some exciting news was published earlier this year in the Psychiatric Journal JAMA, about the potential mental health benefits of psychedelic drug research. It’s likely that within the next 5 years researchers will know whether the psychoactive drug commonly known as ecstasy—methylenedioxymethamphetamine, or MDMA—can be used to treat psychiatric disorders.